Nephros

$8.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.31 (+4.03%) As of 5:12 PM UTC today

Why Robinhood?

You can buy or sell Nephros and other stocks, options, and ETFs commission-free!

About NEPH

Nephros, Inc. Common Stock, also called Nephros, is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Renal Products segment comprises of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ. The listed name for NEPH is Nephros, Inc. Common Stock.

CEO
Andrew Astor
Employees
25
Headquarters
South Orange, New Jersey
Founded
1997
Market Cap
80.15M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
14.97K
High Today
$8.11
Low Today
$7.70
Open Price
$7.70
Volume
3.46K
52 Week High
$10.00
52 Week Low
$4.42

NEPH Earnings

-$0.19
-$0.13
-$0.06
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Today, After Hours
Preview Earnings Call

You May Also Like

VECO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure